XML 45 R34.htm IDEA: XBRL DOCUMENT v3.25.1
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2025
Fair Value Disclosures [Abstract]  
Schedule of Level 3 Investments
The table below presents activity within Level 3 of the fair value hierarchy, our liabilities carried at fair value relating to the medac settlement, for the three months ended March 31, 2025:
Level 3
(In thousands)Contingent
liabilities
Balance at January 1, 2025$974 
Liability fair value adjustment99 
Total change in foreign exchange40 
Balance at March 31, 2025$1,113 
Schedule of Financial Assets and Liabilities Measured at Fair Value
The following tables present information about the Company’s financial assets and liabilities that have been measured at fair value as of March 31, 2025 and December 31, 2024 and indicate the fair value hierarchy of the valuation inputs utilized to determine such fair value.
March 31, 2025
(In thousands)Quoted Prices in
Active Markets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Total
Assets:
Money market funds$11 $— $— $11 
U.S. government agency bonds— 46,120 — 46,120 
Total Assets$11 $46,120 $— $46,131 
Liabilities:
Contingent Liability$— $— $1,113 $1,113 
Total Liabilities$— $— $1,113 $1,113 

December 31, 2024
(In thousands)Quoted Prices in
Active Markets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Total
Assets:
Money market funds$$— $— $
U.S. government agency bonds— 20,821 — 20,821 
Total Assets$$20,821 $— $20,830 
Liabilities:
Contingent Liability$— $— $974 $974 
Total Liabilities$— $— $974 $974